Article Details

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding | BioPharma Dive

Retrieved on: 2025-07-10 22:58:10

Tags for this article:

Click the tags to see associated articles and topics

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding | BioPharma Dive. View article details on hiswai:

Excerpt

... Ventures, Atlas Venture, OrbiMed and Qiming Venture Partners USA. Renasant is the brainchild of a pair of University of California, San Francisco ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo